First-line encorafenib + cetuximab + mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer (BREAKWATER): Progression-free survival and updated overall survival analyses Meeting Abstract
| Authors: | Elez, E.; Yoshino, T.; Shen, L.; Lonardi, S.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; Yaeger, R.; Maughan, T. S.; Morris, V. 2nd; Wu, C.; Usari, T.; Laliberte, R. J.; Dychter, S. S.; Zhang, X.; Tabernero, J.; Kopetz, S. |
| Abstract Title: | First-line encorafenib + cetuximab + mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer (BREAKWATER): Progression-free survival and updated overall survival analyses |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 17 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-10 |
| Start Page: | LBA3500 |
| Language: | English |
| ACCESSION: | WOS:001511767600001 |
| DOI: | 10.1200/JCO.2025.43.17_suppl.LBA3500 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
